Roche Holding Ltd. (ROG) PT Set at CHF 205 by HSBC Holdings PLC

Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 205 target price by stock analysts at HSBC Holdings PLC in a note issued to investors on Tuesday. The brokerage presently has a “sell” rating on the healthcare company’s stock. HSBC Holdings PLC’s price target would indicate a potential downside of 16.94% from the stock’s current price.

A number of other brokerages have also issued reports on ROG. J P Morgan Chase & Co reissued a “buy” rating and issued a price objective on shares of Roche Holding in a report on Thursday, November 2nd. Goldman Sachs Group, Inc. (The) set a CHF 325 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, September 11th. Credit Suisse Group set a CHF 300 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, September 11th. Berenberg Bank set a CHF 260 price objective on shares of Roche Holding and gave the company a “neutral” rating in a report on Tuesday, October 24th. Finally, set a CHF 203 price objective on shares of Roche Holding and gave the company a “sell” rating in a report on Friday, October 20th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. Roche Holding has an average rating of “Hold” and an average target price of CHF 261.78.

Shares of Roche Holding (VTX:ROG) opened at CHF 246.80 on Tuesday. Roche Holding has a 1-year low of CHF 218.30 and a 1-year high of CHF 273.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://transcriptdaily.com/2017/11/23/roche-holding-ltd-rog-pt-set-at-chf-205-by-hsbc-holdings-plc.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply